OticPharma.jpg

OticPharma started at Peregrine’s incubator as the developer of a foam-based medication for the treatment of ear disorders.

The company was merged into Tokai Pharmaceutical and later on changed its product strategy and its name to Eledon Pharmaceutical (NASDAQ: ELDN) , Exit through IPO.

stripBIG-01.jpg

PORTFOLIO

 
icon-08.png

DEVICES

icon-09.png
icon-07.png

PHARMA & BIOTECH

icon-10.png
icon-06.png

PHARMA & BIOTECH

icon-11.png